Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
$3.33M Buy
49,198
+1,320
+3% +$84.1K 0.46% 84
2018
Q2
$2.77M Sell
47,878
-417
-0.9% -$23.5K 0.4% 93
2018
Q1
$2.51M Buy
48,295
+2,014
+4% +$109K 0.28% 123
2017
Q4
$2.48M Sell
46,281
-692
-1% -$38.4K 0.27% 126
2017
Q3
$2.87M Buy
46,973
+8,454
+22% +$513K 0.35% 117
2017
Q2
$2.36M Buy
38,519
+4,891
+15% +$298K 0.3% 125
2017
Q1
$2.04M Buy
33,628
+946
+3% +$57.4K 0.28% 125
2016
Q4
$1.84M Buy
32,682
+5,895
+22% +$345K 0.28% 118
2016
Q3
$1.59M Sell
26,787
-121
-0.4% -$7.08K 0.25% 124
2016
Q2
$1.48M Sell
26,908
-219
-0.8% -$11.7K 0.24% 133
2016
Q1
$1.37M Buy
27,127
+1,278
+5% +$62.6K 0.22% 133
2015
Q4
$1.3M Buy
+25,849
New +$1.3M 0.2% 133
2014
Q1
Sell
-35,948
Closed -$1.72M 150
2013
Q4
$1.72M Buy
35,948
+1,187
+3% +$54.3K 0.23% 109
2013
Q3
$1.58M Buy
34,761
+597
+2% +$27.3K 0.22% 108
2013
Q2
$1.51M Buy
+34,164
New +$1.53M 0.21% 111

Other funds holding MRK

AFAM Capital's MRK Position: Q3 2018 in Review

AFAM Capital increased its Merck (MRK) stake by 2.8% in Q3 2018, buying an estimated $84.1K and bringing the position to 49,198 shares worth $3.33M. The position accounts for 0.46% of the portfolio, ranked #84.

AFAM Capital first reported a position in MRK in Q2 2013 and has held it in 15 quarters since. 2,056 funds tracked by Wall St. Rank hold MRK as of Q3 2018.

  • AFAM Capital held 49,198 shares of Merck worth $3.33M as of Q3 2018.
  • AFAM Capital bought 1,320 Merck shares in Q3 2018, an estimated $84.1K.
  • Merck made up 0.46% of AFAM Capital's portfolio in Q3 2018, its #84 holding.
  • AFAM Capital first reported a position in Merck in Q2 2013 and has held it in 15 quarters since.
  • 2,056 funds tracked by Wall St. Rank held Merck as of Q3 2018.

Based on AFAM Capital's 13F filing for Q3 2018, filed 14 Nov 2018.